Literature DB >> 18060428

Plasmodium malariae infection in spite of previous anti-malarial medication.

Irmela Müller-Stöver1, Jaco J Verweij, Barbara Hoppenheit, Klaus Göbels, Dieter Häussinger, Joachim Richter.   

Abstract

Plasmodium malariae is regarded as usually being susceptible to all anti-malarials whether applied for prophylaxis or treatment. We report on three cases of P. malariae infection which occurred 12-14 weeks after anti-malarial chemoprophylaxis or treatment with mefloquine or atovaquone/proguanil. The most likely explanation for the failure of mefloquine and atovaquone/proguanil to prevent quartan malaria occurring some months later is the insufficient effect on the particularly long-lasting pre-erythrocytic development stages of P. malariae.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18060428     DOI： 10.1007/s00436-007-0804-4

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


  9 in total

Review 1.  Clinical virology in real time.

Authors:  Hubert G M Niesters
Journal:  J Clin Virol       Date:  2002-12       Impact factor: 3.168

2.  Is quartan malaria safely prevented by mefloquine prophylaxis?

Authors:  Martin P Grobusch; Klaus Göbels; Dieter Teichmann
Journal:  J Travel Med       Date:  2004 Mar-Apr       Impact factor: 8.490

3.  Patterns of imported malaria at the academic medical center, Amsterdam, the Netherlands.

Authors:  Marije C Baas; José C F M Wetsteyn; Tom van Gool
Journal:  J Travel Med       Date:  2006 Jan-Feb       Impact factor: 8.490

4.  Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.

Authors:  P D Radloff; J Philipps; D Hutchinson; P G Kremsner
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Nov-Dec       Impact factor: 2.184

5.  Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.

Authors:  I K Srivastava; J M Morrisey; E Darrouzet; F Daldal; A B Vaidya
Journal:  Mol Microbiol       Date:  1999-08       Impact factor: 3.501

6.  Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.

Authors:  B Høgh; P D Clarke; D Camus; H D Nothdurft; D Overbosch; M Günther; I Joubert; K C Kain; D Shaw; N S Roskell; J D Chulay
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

7.  Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight.

Authors:  Ayôla A Adegnika; Jaco J Verweij; Selidji T Agnandji; Sanders K Chai; Lutz Ph Breitling; Michael Ramharter; Marijke Frolich; Saadou Issifou; Peter G Kremsner; Maria Yazdanbakhsh
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

8.  Problems in the therapy of mixed malarial infections: a case of infection with Plasmodium falciparum and P. malariae treated with mefloquine and halofantrine.

Authors:  F J Hess; H D Kilian; H D Nothdurft; T Löscher
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Nov-Dec       Impact factor: 2.184

9.  Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia.

Authors:  Jason D Maguire; Iwa W Sumawinata; Sofyan Masbar; Budhi Laksana; Purnomo Prodjodipuro; Ika Susanti; Priyanto Sismadi; Nurlis Mahmud; Michael J Bangs; J Kevin Baird
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321
  9 in total
  12 in total

Review 1.  What is the evidence for the existence of Plasmodium ovale hypnozoites?

Authors:  Joachim Richter; Gabriele Franken; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

2.  Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?

Authors:  Gabriele Franken; Irmela Müller-Stöver; Martha C Holtfreter; Susanne Walter; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger; Joachim Richter
Journal:  Parasitol Res       Date:  2012-02-18       Impact factor: 2.289

3.  Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study).

Authors:  Aprilianto E Wiria; Margaretta A Prasetyani; Firdaus Hamid; Linda J Wammes; Bertrand Lell; Iwan Ariawan; Hae Won Uh; Heri Wibowo; Yenny Djuardi; Sitti Wahyuni; Inge Sutanto; Linda May; Adrian J F Luty; Jaco J Verweij; Erliyani Sartono; Maria Yazdanbakhsh; Taniawati Supali
Journal:  BMC Infect Dis       Date:  2010-03-25       Impact factor: 3.090

4.  High prevalence and genetic diversity of Plasmodium malariae and no evidence of Plasmodium knowlesi in Bangladesh.

Authors:  Hans-Peter Fuehrer; Paul Swoboda; Josef Harl; Peter Starzengruber; Verena Elisabeth Habler; Ingrid Bloeschl; Rashidul Haque; Julia Matt; Wasif Ali Khan; Harald Noedl
Journal:  Parasitol Res       Date:  2014-02-28       Impact factor: 2.289

5.  Polymorphisms in TLR4 and TLR2 genes, cytokine production and survival in rural Ghana.

Authors:  Linda May; David van Bodegom; Marijke Frölich; Lisette van Lieshout; P Eline Slagboom; Rudi G J Westendorp; Maris Kuningas
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

6.  Multiplex real-time PCR for diagnosing malaria in a non-endemic setting: a prospective comparison to conventional methods.

Authors:  R H T Nijhuis; L van Lieshout; J J Verweij; E C J Claas; E Wessels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-26       Impact factor: 3.267

Review 7.  Clinical implications of a gradual dormancy concept in malaria.

Authors:  Joachim Richter; Gabriele Franken; Martha C Holtfreter; Susanne Walter; Alfons Labisch; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2016-04-15       Impact factor: 2.289

8.  Human Plasmodium knowlesi infection detected by rapid diagnostic tests for malaria.

Authors:  Jaap J van Hellemond; Marijke Rutten; Rob Koelewijn; Anne Marie Zeeman; Jaco J Verweij; Pieter J Wismans; Clemens H Kocken; Perry J J van Genderen
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

9.  A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species.

Authors:  Steve M Taylor; Alfredo Mayor; Ghyslain Mombo-Ngoma; Hilaire M Kenguele; Smaïla Ouédraogo; Nicaise Tuikue Ndam; Happy Mkali; Grace Mwangoka; Neena Valecha; Jai Prakash Narayan Singh; Martha A Clark; Jaco J Verweij; Ayola Akim Adegnika; Carlo Severini; Michela Menegon; Eusebio Macete; Clara Menendez; Pau Cisteró; Fanta Njie; Muna Affara; Kephas Otieno; Simon Kariuki; Feiko O ter Kuile; Steven R Meshnick
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

10.  Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCR.

Authors:  Maria M M Kaisar; Taniawati Supali; Aprilianto E Wiria; Firdaus Hamid; Linda J Wammes; Erliyani Sartono; Adrian J F Luty; Eric A T Brienen; Maria Yazdanbakhsh; Lisette van Lieshout; Jaco J Verweij
Journal:  Malar J       Date:  2013-05-24       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.